These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 1686134)
61. Growth hormone blocking antibodies in a patient with deletion of the GH-N gene. Schwarz S; Berger P; Frisch H; Moncayo R; Phillips JA; Wick G Clin Endocrinol (Oxf); 1987 Aug; 27(2):213-24. PubMed ID: 3665129 [TBL] [Abstract][Full Text] [Related]
62. Measurement of plasma free and total growth hormone concentrations in patients with growth hormone antibodies developed in response to therapy. Demura R; Ishiwatari N; Nomura T; Demura H; Shizume K; Okuno A; Sanayama K; Fujieda K Acta Endocrinol (Copenh); 1989 Feb; 120(2):161-9. PubMed ID: 2916377 [TBL] [Abstract][Full Text] [Related]
63. Growth response to growth hormone during the first year as a diagnosis criterion of growth hormone deficiency. Zantleifer D; Awadalla S; Brauner R Horm Res; 1993; 40(4):123-7. PubMed ID: 8300059 [TBL] [Abstract][Full Text] [Related]
64. Partial rescue of growth failure in growth hormone (GH)-deficient mice by a single injection of a double-stranded adeno-associated viral vector expressing the GH gene driven by a muscle-specific regulatory cassette. Martari M; Sagazio A; Mohamadi A; Nguyen Q; Hauschka SD; Kim E; Salvatori R Hum Gene Ther; 2009 Jul; 20(7):759-66. PubMed ID: 19298131 [TBL] [Abstract][Full Text] [Related]
65. Single and multiple dose pharmacokinetics of methionyl growth hormone in children with idiopathic growth hormone deficiency. Kearns GL; Kemp SF; Frindik JP J Clin Endocrinol Metab; 1991 May; 72(5):1148-56. PubMed ID: 2022713 [TBL] [Abstract][Full Text] [Related]
66. Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test? Cianfarani S; Tondinelli T; Spadoni GL; Scirè G; Boemi S; Boscherini B Clin Endocrinol (Oxf); 2002 Aug; 57(2):161-7. PubMed ID: 12153594 [TBL] [Abstract][Full Text] [Related]
67. Body proportions before and during growth hormone therapy in children with chronic renal failure. de Graaff LC; Mulder PG; Hokken-Koelega AC Pediatr Nephrol; 2003 Jul; 18(7):679-84. PubMed ID: 12734746 [TBL] [Abstract][Full Text] [Related]
68. Growth hormone measurements versus auxology in treatment decisions: the Australian experience. Werther GA J Pediatr; 1996 May; 128(5 Pt 2):S47-51. PubMed ID: 8627470 [TBL] [Abstract][Full Text] [Related]
69. Monitoring serum insulin-like growth factor-I (IGF-I), IGF binding protein-3 (IGFBP-3), IGF-I/IGFBP-3 molar ratio and leptin during growth hormone treatment for disordered growth. Tillmann V; Patel L; Gill MS; Whatmore AJ; Price DA; Kibirige MS; Wales JK; Clayton PE Clin Endocrinol (Oxf); 2000 Sep; 53(3):329-36. PubMed ID: 10971450 [TBL] [Abstract][Full Text] [Related]
70. Short stature associated with high circulating insulin-like growth factor (IGF)-binding protein-1 and low circulating IGF-II: effect of growth hormone therapy. Barreca A; Bozzola M; Cesarone A; Steenbergh PH; Holthuizen PE; Severi F; Giordano G; Minuto F J Clin Endocrinol Metab; 1998 Oct; 83(10):3534-41. PubMed ID: 9768660 [TBL] [Abstract][Full Text] [Related]
71. Is IGF binding protein-3 assessment helpful for the diagnosis of GH deficiency? Cianfarani S; Boemi S; Spagnoli A; Cappa M; Argirò G; Vaccaro F; Manca Bitti ML; Boscherini B Clin Endocrinol (Oxf); 1995 Jul; 43(1):43-7. PubMed ID: 7543832 [TBL] [Abstract][Full Text] [Related]
72. [Intra-uterine growth retardation: an indication for treatment with growth hormone?]. Hokken-Koelega AC Tijdschr Kindergeneeskd; 1992 Oct; 60(5):173-6. PubMed ID: 1448807 [TBL] [Abstract][Full Text] [Related]
73. The growth hormone receptor exon 3-deleted/full-length polymorphism and response to growth hormone therapy in prepubertal idiopathic short children. Hellgren G; Glad CA; Jonsson B; Johannsson G; Albertsson-Wikland K Growth Horm IGF Res; 2015 Jun; 25(3):127-35. PubMed ID: 25742716 [TBL] [Abstract][Full Text] [Related]
74. Evaluation of growth disorders in the paediatric clinic. Cappa M; Loche S J Endocrinol Invest; 2003; 26(7 Suppl):54-63. PubMed ID: 14604067 [TBL] [Abstract][Full Text] [Related]
75. Glucagon stimulation test for childhood growth hormone deficiency: timing of the peak is important. Strich D; Terespolsky N; Gillis D J Pediatr; 2009 Mar; 154(3):415-9. PubMed ID: 18950790 [TBL] [Abstract][Full Text] [Related]
76. Growth hormone state after completion of treatment with growth hormone. Clayton PE; Price DA; Shalet SM Arch Dis Child; 1987 Mar; 62(3):222-6. PubMed ID: 3566314 [TBL] [Abstract][Full Text] [Related]
78. Growth and adult height in GH-treated children with nonacquired GH deficiency and idiopathic short stature: the influence of pituitary magnetic resonance imaging findings. Coutant R; Rouleau S; Despert F; Magontier N; Loisel D; Limal JM J Clin Endocrinol Metab; 2001 Oct; 86(10):4649-54. PubMed ID: 11600520 [TBL] [Abstract][Full Text] [Related]
79. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy? Rogol AD; Blethen SL; Sy JP; Veldhuis JD Clin Endocrinol (Oxf); 2003 Feb; 58(2):229-37. PubMed ID: 12580940 [TBL] [Abstract][Full Text] [Related]
80. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age. Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]